TCNNF Trulieve Cannabis Corp.

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, and Connecticut, as well as directly to patients through home delivery. It produces approximately 155 stock keeping units, including smokable flower, flower pods for vaporizing, concentrates, topicals, capsules, tinctures, and vape cartridges. As of May 05, 2020, the company operated through 49 dispensaries, which included 47 locations in Florida. Trulieve Cannabis Corp. is headquartered in Quincy, Florida.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol CT:TRUL.

$12.80    OTCQX
As of 06/28/2022     OTCMarkets

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  
IPO date:  09/27/2018
Outstanding shares:  128,536,507
Average volume:  216,619
Market cap:   $1,683,828,242
Current dividend yield:  0.00%
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%